Moreover, it has been suggested that the risk of T2DM, as associated with statin therapy, can be attributed to a genetic predisposition for increased levels of LDL-C in patients with a lower incidence of T2DM [18–20]. Here, COG2 is linked to type 2 diabetes mellitus.